In an opinion today, Judge McMahon denied Novartis’ motion to dismiss the government’s False Claims Act suit (covered in this prior post), which accuses Novartis of giving certain specialty pharmacies  “rebates” — which the government considers kickbacks — to have them switch their patients to two Novartis drugs, Exjade and Myfortic.  The alleged scheme resulted in Medicare and Medicaid paying for claims that were tainted by the alleged kickbacks. Novartis argued that the complaint did not specify which specific prescriptions were false, but Judge McMahon found the complaint sufficiently detailed:
Continue Reading Judge McMahon Allows Kickback Suit Against Novartis to Proceed